Skip to content
HeyJared

Ryan B. Thurber

Reporter

Indexed articles, last 90 days
1
Latest publication
Jul 16, 2026
Outlet visibility, for natlawreview.com
Top 1M sites
Earliest in this view
Jul 16, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 16, 2026 · Ryan B. Thurber

    Peptides Take Center Stage at FDA’s Critical Stakeholder Meeting (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    As discussed in our previous alert, the U.S. Food and Drug Administration’s (FDA) much-anticipated Pharmacy Compounding Advisory Committee (PCAC) meeting is scheduled for July 23–24. The PCAC will discuss whether seven peptides should be included on the list of bulk drug substances that may be used in compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. Although the July 9 deadline for submitting comments for distribution to committee members has passed, the FDA’s public d

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 1M sites

For natlawreview.com, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Ryan B. Thurber